<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Familial hyperlipidemia type 4" Version="20210520" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Familial hyperlipidemias are classified according to the Fredrickson classification. Type IV familial hyperlipidemia is also known as familial hypertriglyceridemia. Typ IV is mostly linked to in increased VLDL within the blood. This is from both an increased production as well as a decreased elimination of VLDL. 
The increased production is caused by mutations of GCKR. This gene inhibits glucokinase, which would lead to less triglycerides produced in the liver. These triglycerides would then increase the amount of VLDL in the blood. Mutations in GCKR would therefore lead to increased VLDL. 
A decreased elimination is caused by APOA5. APOA5 plays a role in the hydrolysis of VDLD by LPL. Mutations in this gene would therefore lead to a decrease of this hydrolysis.</Comment>
  <Graphics BoardWidth="1295.5837051888334" BoardHeight="769.6184955480411"/>
  <DataNode TextLabel="Malonyl-CoA" GraphId="bd48f" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="DGAT2" GraphId="c1734" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Glucokinase" GraphId="c4fd5" Type="Protein">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="GCKR" GraphId="c57ee" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="FAS" GraphId="ee7be" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Familial hypertriglyceridemia" GraphId="b5461">
    <Graphics ShapeType="RoundedRectangle"/>
    </DataNode>
  <DataNode TextLabel="Familial hyperlipidemia" GraphId="f6d3e">
    <Graphics ShapeType="RoundedRectangle"/>
    </DataNode>
  <DataNode TextLabel="SEL1L" GraphId="f1365" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="VLDL" GraphId="c28b3" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="APOA2" GraphId="c247c" Type="GeneProduct" GroupRef="d6e81">
        </DataNode>
  <DataNode TextLabel="Cholesterol" GraphId="b475d" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="HDL" GraphId="cbade" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="LDL" GraphId="a50d6" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="LRP1" GraphId="d48d4" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="APOA4" GraphId="cedda" Type="GeneProduct" GroupRef="d6e81">
        </DataNode>
  <DataNode TextLabel="Lipoprotein" GraphId="c39cc" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="IDL" GraphId="d5e94" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="CETP" GraphId="f3bba" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="LIPC" GraphId="b585b" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="APOA1" GraphId="e2bcf" Type="GeneProduct" GroupRef="d6e81">
        </DataNode>
  <DataNode TextLabel="LCAT" GraphId="a13ac" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="LDLR" GraphId="ec1bf" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="PLTP" GraphId="e923d" Type="GeneProduct" GroupRef="d6e81">
        </DataNode>
  <DataNode TextLabel="LPL" GraphId="f9d2e" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="LMF1" GraphId="d283a" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="GPIHBP1" GraphId="e5c53" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="GPIHBP1" GraphId="f0605" Type="GeneProduct" GroupRef="b2595">
        </DataNode>
  <DataNode TextLabel="LPL" GraphId="ef58b" Type="GeneProduct" GroupRef="b2595">
        </DataNode>
  <DataNode TextLabel="APOC2" GraphId="db6b1" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="APOA5" GraphId="ae4fc" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="CETP" GraphId="e5589" Type="GeneProduct">
    <BiopaxRef>d5e</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="CETP" GraphId="ff90d" Type="GeneProduct">
        </DataNode>
  <DataNode TextLabel="Fatty acid" GraphId="b9ae5" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Acyl-CoA" GraphId="ae930" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Acyl-CoA synthetase" GraphId="d536f" Type="Protein">
        </DataNode>
  <DataNode TextLabel="Triglyceride" GraphId="c5b2f" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="PDIA2" GraphId="a451c" Type="GeneProduct" GroupRef="d1e3f">
        </DataNode>
  <DataNode TextLabel="MTTP" GraphId="ab12c" Type="GeneProduct" GroupRef="d1e3f">
        </DataNode>
  <DataNode TextLabel="Triglyceride" GraphId="dfcad" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Cholesterol" GraphId="af33d" Type="Metabolite" GroupRef="e1f56">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Triglyceride" GraphId="b870e" Type="Metabolite" GroupRef="e1f56">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Phospholipid" GraphId="c3eac" Type="Metabolite" GroupRef="e1f56">
    <Graphics Color="0000ff"/>
    </DataNode>
  <Interaction GraphId="id1645e873">
    <BiopaxRef>d10</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="ee7be"/>
      <Point/>
      <Point/>
      <Point GraphRef="f5312" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id20613d03">
    <BiopaxRef>ea2</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="c5b2f"/>
      <Point GraphRef="f8489" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id528771cc">
    <BiopaxRef>d10</BiopaxRef>
    <Graphics>
      <Point GraphRef="c1734"/>
      <Point GraphRef="dc099" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id5ac4a1cd">
    <BiopaxRef>c66</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="dfcad"/>
      <Point GraphRef="c28b3" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id7fffe664">
    <BiopaxRef>d10</BiopaxRef>
    <Graphics>
      <Point GraphRef="ae930"/>
      <Point GraphRef="c5b2f" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="dc099"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idb952068a">
    <BiopaxRef>c66</BiopaxRef>
    <Graphics>
      <Point GraphRef="c57ee"/>
      <Point GraphRef="c4fd5" ArrowHead="TBar"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="iddb10ffdf">
    <BiopaxRef>d10</BiopaxRef>
    <Graphics>
      <Point GraphRef="b9ae5"/>
      <Point GraphRef="ae930" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="c92ee"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ideb02aaf2">
    <BiopaxRef>c66</BiopaxRef>
    <Graphics>
      <Point GraphRef="c4fd5"/>
      <Point GraphRef="bd48f" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idfa8db7b3">
    <BiopaxRef>d10</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="bd48f"/>
      <Point GraphRef="b9ae5" ArrowHead="mim-conversion"/>
      <Anchor Position="0.24444435260665742" Shape="None" GraphId="f5312"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f1106">
    <BiopaxRef>edb</BiopaxRef>
    <Graphics>
      <Point GraphRef="e5589"/>
      <Point GraphRef="d1e4d" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bcd2b">
    <BiopaxRef>fdd</BiopaxRef>
    <Graphics>
      <Point GraphRef="c52b5"/>
      <Point GraphRef="a9a41" ArrowHead="mim-catalysis"/>
      <Anchor Position="0.22273617500313048" Shape="None" GraphId="ae22c"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aad52">
    <BiopaxRef>fdd</BiopaxRef>
    <Graphics>
      <Point GraphRef="d283a"/>
      <Point GraphRef="f9d2e" ArrowHead="mim-stimulation"/>
      <Anchor Position="0.4" Shape="None" GraphId="d28ba"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a37e7">
    <BiopaxRef>fdd</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="f9d2e"/>
      <Point GraphRef="e5c53" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a6384">
    <BiopaxRef>fdd</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="db6b1"/>
      <Point/>
      <Point GraphRef="ae22c" ArrowHead="mim-stimulation"/>
      <Anchor Position="0.60168471031344" Shape="None" GraphId="fb584"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a7f78">
    <BiopaxRef>fdd</BiopaxRef>
    <Graphics>
      <Point GraphRef="f1365"/>
      <Point GraphRef="d28ba" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="afbf2">
    <BiopaxRef>fdd</BiopaxRef>
    <Graphics>
      <Point GraphRef="ae4fc"/>
      <Point GraphRef="fb584" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c379f">
    <BiopaxRef>fdd</BiopaxRef>
    <Graphics>
      <Point GraphRef="e5c53"/>
      <Point GraphRef="c52b5" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f8e8a">
    <BiopaxRef>bab</BiopaxRef>
    <Graphics>
      <Point GraphRef="a13ac"/>
      <Point GraphRef="cd7a5" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="edb18">
    <BiopaxRef>f2e</BiopaxRef>
    <BiopaxRef>edb</BiopaxRef>
    <BiopaxRef>d5e</BiopaxRef>
    <Graphics>
      <Point GraphRef="f3bba"/>
      <Point GraphRef="e70fa" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f47d8">
    <BiopaxRef>c65</BiopaxRef>
    <BiopaxRef>b37</BiopaxRef>
    <BiopaxRef>bab</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="c39cc"/>
      <Point/>
      <Point GraphRef="cbade" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5837617349949994" Shape="None" GraphId="b351a"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e1492">
    <BiopaxRef>f2e</BiopaxRef>
    <Graphics>
      <Point GraphRef="c28b3"/>
      <Point GraphRef="d5e94" ArrowHead="mim-conversion"/>
      <Anchor Position="0.2398777074349988" Shape="None" GraphId="a9a41"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aacf6">
    <Comment>transport</Comment>
    <BiopaxRef>cbc</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="d5e94"/>
      <Point GraphRef="d48d4" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="adcfa">
    <BiopaxRef>bab</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="b475d"/>
      <Point/>
      <Point GraphRef="cbade" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5875744032609194" Shape="None" GraphId="cd7a5"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d1aca">
    <BiopaxRef>bbc</BiopaxRef>
    <BiopaxRef>c65</BiopaxRef>
    <BiopaxRef>b52</BiopaxRef>
    <BiopaxRef>bab</BiopaxRef>
    <Graphics>
      <Point GraphRef="c7f9c"/>
      <Point GraphRef="b351a" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ccaab">
    <BiopaxRef>f2e</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="cbade"/>
      <Point GraphRef="d5e94" ArrowHead="mim-conversion"/>
      <Anchor Position="0.8265298009022469" Shape="None" GraphId="e70fa"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ccc05">
    <Comment>transport</Comment>
    <BiopaxRef>d2a</BiopaxRef>
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="ec1bf"/>
      <Point GraphRef="f16fc" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ce2fb">
    <BiopaxRef>f2e</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="cbade"/>
      <Point GraphRef="c28b3" ArrowHead="mim-conversion"/>
      <Anchor Position="0.7473603989526273" Shape="None" GraphId="d1e4d"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ebfa8">
    <Comment>transport</Comment>
    <BiopaxRef>cbc</BiopaxRef>
    <BiopaxRef>d2a</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="a50d6"/>
      <Point GraphRef="ec1bf" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b22f4">
    <BiopaxRef>f2e</BiopaxRef>
    <Graphics>
      <Point GraphRef="d5e94"/>
      <Point GraphRef="a50d6" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="a6780"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a0520">
    <BiopaxRef>d5e</BiopaxRef>
    <Graphics>
      <Point GraphRef="b585b"/>
      <Point GraphRef="a6780" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fdfb2">
    <Comment>transport</Comment>
    <BiopaxRef>d2a</BiopaxRef>
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="d48d4"/>
      <Point GraphRef="f16fc" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ce0ac">
    <BiopaxRef>f2e</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="c28b3"/>
      <Point GraphRef="cbade" ArrowHead="mim-conversion"/>
      <Anchor Position="0.25151666476946377" Shape="None" GraphId="c9e59"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dcc9d">
    <BiopaxRef>f2e</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="d5e94"/>
      <Point GraphRef="cbade" ArrowHead="mim-conversion"/>
      <Anchor Position="0.13818132022889612" Shape="None" GraphId="dd7bc"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eab72">
    <BiopaxRef>f2e</BiopaxRef>
    <BiopaxRef>edb</BiopaxRef>
    <BiopaxRef>d5e</BiopaxRef>
    <Graphics>
      <Point GraphRef="ff90d"/>
      <Point GraphRef="c9e59" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f6cee">
    <BiopaxRef>f2e</BiopaxRef>
    <BiopaxRef>edb</BiopaxRef>
    <BiopaxRef>d5e</BiopaxRef>
    <Graphics>
      <Point GraphRef="ff90d"/>
      <Point GraphRef="dd7bc" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ce08b">
    <BiopaxRef>d10</BiopaxRef>
    <Graphics>
      <Point GraphRef="d536f"/>
      <Point GraphRef="c92ee" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a5290">
    <BiopaxRef>ea2</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="f8489"/>
      <Point GraphRef="dfcad" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <GraphicalLine GraphId="cc581">
    <BiopaxRef>ce8</BiopaxRef>
    <BiopaxRef>bb5</BiopaxRef>
    <Graphics ConnectorType="Elbow" Color="ff0000">
      <Point GraphRef="c57ee"/>
      <Point GraphRef="b5461" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ee5c2">
    <BiopaxRef>ce8</BiopaxRef>
    <BiopaxRef>bb5</BiopaxRef>
    <Graphics ConnectorType="Elbow" Color="ff0000">
      <Point GraphRef="ae4fc"/>
      <Point GraphRef="b5461" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="a8dca">
    <Graphics>
      <Point GraphRef="f6d3e"/>
      <Point GraphRef="a3eba" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c8aa5">
    <Graphics>
      <Point GraphRef="a3eba"/>
      <Point GraphRef="b5461" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="da4f0">
    <Graphics LineStyle="Broken">
      <Point/>
      <Point GraphRef="b2880" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e44e3">
    <Graphics>
      <Point/>
      <Point GraphRef="c4998" ArrowHead="mim-binding"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b9f81">
    <Graphics>
      <Point/>
      <Point GraphRef="b23ad" ArrowHead="mim-conversion"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f78ac">
    <Graphics>
      <Point/>
      <Point GraphRef="f46da" ArrowHead="mim-stimulation"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="fdfb9">
    <Graphics>
      <Point/>
      <Point GraphRef="eb6f4" ArrowHead="mim-inhibition"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b0682">
    <Graphics>
      <Point/>
      <Point GraphRef="d0e7c" ArrowHead="mim-catalysis"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c1a2e">
    <Graphics Color="ff0000">
      <Point/>
      <Point GraphRef="cb40e" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <Label TextLabel="Type IV" GraphId="a3eba">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Liver" GraphId="bf393">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Transport&#10;" GraphId="b2880">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Binding" GraphId="c4998">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Inhibition" GraphId="eb6f4">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Conversion" GraphId="b23ad">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Gene/protein" GraphId="b5f7b">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Metabolite" GraphId="c5d25">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Catalysis" GraphId="d0e7c">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Stimulation" GraphId="f46da">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Mutations" GraphId="cb40e">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Legend" GraphId="a0828">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Shape GraphId="faf28">
    <Graphics ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <Shape TextLabel="x" GraphId="eebd5">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape GraphId="c3dc6">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape TextLabel="x" GraphId="ff261">
    <Graphics ShapeType="Rectangle" Color="0000ff"/>
  </Shape>
  <Group GroupId="b2595" GraphId="c52b5" Style="Complex"/>
  <Group GroupId="d6e81" GraphId="c7f9c" Style="Complex"/>
  <Group GroupId="e1f56" GraphId="f16fc" Style="Group"/>
  <Group GroupId="d1e3f" GraphId="f8489" Style="Complex"/>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c66">
      <bp:ID >22281838</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Unraveling the genetics of fatty liver in obese children: additive effect of P446L GCKR and I148M PNPLA3 polymorphisms.</bp:TITLE>
      <bp:SOURCE >Hepatology</bp:SOURCE>
      <bp:YEAR >2012</bp:YEAR>
      <bp:AUTHORS >Valenti L</bp:AUTHORS>
      <bp:AUTHORS >Alisi A</bp:AUTHORS>
      <bp:AUTHORS >Nobili V</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c63">
      <bp:ID >25470695</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Targeting APOC3 in the familial chylomicronemia syndrome.</bp:TITLE>
      <bp:SOURCE >N Engl J Med</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Gaudet D</bp:AUTHORS>
      <bp:AUTHORS >Brisson D</bp:AUTHORS>
      <bp:AUTHORS >Tremblay K</bp:AUTHORS>
      <bp:AUTHORS >Alexander VJ</bp:AUTHORS>
      <bp:AUTHORS >Singleton W</bp:AUTHORS>
      <bp:AUTHORS >Hughes SG</bp:AUTHORS>
      <bp:AUTHORS >Geary RS</bp:AUTHORS>
      <bp:AUTHORS >Baker BF</bp:AUTHORS>
      <bp:AUTHORS >Graham MJ</bp:AUTHORS>
      <bp:AUTHORS >Crooke RM</bp:AUTHORS>
      <bp:AUTHORS >Witztum JL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bb5">
      <bp:ID >20657596</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia.</bp:TITLE>
      <bp:SOURCE >Nat Genet</bp:SOURCE>
      <bp:YEAR >2010</bp:YEAR>
      <bp:AUTHORS >Johansen CT</bp:AUTHORS>
      <bp:AUTHORS >Wang J</bp:AUTHORS>
      <bp:AUTHORS >Lanktree MB</bp:AUTHORS>
      <bp:AUTHORS >Cao H</bp:AUTHORS>
      <bp:AUTHORS >McIntyre AD</bp:AUTHORS>
      <bp:AUTHORS >Ban MR</bp:AUTHORS>
      <bp:AUTHORS >Martins RA</bp:AUTHORS>
      <bp:AUTHORS >Kennedy BA</bp:AUTHORS>
      <bp:AUTHORS >Hassell RG</bp:AUTHORS>
      <bp:AUTHORS >Visser ME</bp:AUTHORS>
      <bp:AUTHORS >Schwartz SM</bp:AUTHORS>
      <bp:AUTHORS >Voight BF</bp:AUTHORS>
      <bp:AUTHORS >Elosua R</bp:AUTHORS>
      <bp:AUTHORS >Salomaa V</bp:AUTHORS>
      <bp:AUTHORS >O'Donnell CJ</bp:AUTHORS>
      <bp:AUTHORS >Dallinga-Thie GM</bp:AUTHORS>
      <bp:AUTHORS >Anand SS</bp:AUTHORS>
      <bp:AUTHORS >Yusuf S</bp:AUTHORS>
      <bp:AUTHORS >Huff MW</bp:AUTHORS>
      <bp:AUTHORS >Kathiresan S</bp:AUTHORS>
      <bp:AUTHORS >Hegele RA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d10">
      <bp:ID >21811631</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression.</bp:TITLE>
      <bp:SOURCE >PLoS One</bp:SOURCE>
      <bp:YEAR >2011</bp:YEAR>
      <bp:AUTHORS >Jeong YS</bp:AUTHORS>
      <bp:AUTHORS >Kim D</bp:AUTHORS>
      <bp:AUTHORS >Lee YS</bp:AUTHORS>
      <bp:AUTHORS >Kim HJ</bp:AUTHORS>
      <bp:AUTHORS >Han JY</bp:AUTHORS>
      <bp:AUTHORS >Im SS</bp:AUTHORS>
      <bp:AUTHORS >Chong HK</bp:AUTHORS>
      <bp:AUTHORS >Kwon JK</bp:AUTHORS>
      <bp:AUTHORS >Cho YH</bp:AUTHORS>
      <bp:AUTHORS >Kim WK</bp:AUTHORS>
      <bp:AUTHORS >Osborne TF</bp:AUTHORS>
      <bp:AUTHORS >Horton JD</bp:AUTHORS>
      <bp:AUTHORS >Jun HS</bp:AUTHORS>
      <bp:AUTHORS >Ahn YH</bp:AUTHORS>
      <bp:AUTHORS >Ahn SM</bp:AUTHORS>
      <bp:AUTHORS >Cha JY</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f2e">
      <bp:ID >26247089</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Introduction to Lipids and Lipoproteins</bp:TITLE>
      <bp:SOURCE />
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Feingold KR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f4b">
      <bp:ID >28882953</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >&lt;i&gt;SCARB1&lt;/i&gt;Gene Polymorphisms and HDL Subfractions in Coronary Artery Disease.</bp:TITLE>
      <bp:SOURCE >In Vivo</bp:SOURCE>
      <bp:YEAR >2017</bp:YEAR>
      <bp:AUTHORS >Ayhan H</bp:AUTHORS>
      <bp:AUTHORS >Gormus U</bp:AUTHORS>
      <bp:AUTHORS >Isbir S</bp:AUTHORS>
      <bp:AUTHORS >Yilmaz SG</bp:AUTHORS>
      <bp:AUTHORS >Isbir T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c72">
      <bp:ID >22474067</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted indyslipidemic patients with coronary artery disease.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >2012</bp:YEAR>
      <bp:AUTHORS >Pillois X</bp:AUTHORS>
      <bp:AUTHORS >Gautier T</bp:AUTHORS>
      <bp:AUTHORS >Bouillet B</bp:AUTHORS>
      <bp:AUTHORS >Pais de Barros JP</bp:AUTHORS>
      <bp:AUTHORS >Jeannin A</bp:AUTHORS>
      <bp:AUTHORS >Verg&#195;&#402;&#194;&#168;s B</bp:AUTHORS>
      <bp:AUTHORS >Bonnet J</bp:AUTHORS>
      <bp:AUTHORS >Lagrost L</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >familial hyperlipidemia</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:1168</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b37">
      <bp:ID >30333156</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Genetic and secondary causes of severe HDL deficiency and cardiovascular disease.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Geller AS</bp:AUTHORS>
      <bp:AUTHORS >Polisecki EY</bp:AUTHORS>
      <bp:AUTHORS >Diffenderfer MR</bp:AUTHORS>
      <bp:AUTHORS >Asztalos BF</bp:AUTHORS>
      <bp:AUTHORS >Karathanasis SK</bp:AUTHORS>
      <bp:AUTHORS >Hegele RA</bp:AUTHORS>
      <bp:AUTHORS >Schaefer EJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d5e">
      <bp:ID >24426196</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Association of CETP and LIPC Gene Polymorphisms with HDL and LDL Sub-fraction Levels in a Group of Indian Subjects: A Cross-Sectional Study.</bp:TITLE>
      <bp:SOURCE >Indian J Clin Biochem</bp:SOURCE>
      <bp:YEAR >2013</bp:YEAR>
      <bp:AUTHORS >Todur SP</bp:AUTHORS>
      <bp:AUTHORS >Ashavaid TF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b52">
      <bp:ID >31462513</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >2019</bp:YEAR>
      <bp:AUTHORS >Obinata H</bp:AUTHORS>
      <bp:AUTHORS >Kuo A</bp:AUTHORS>
      <bp:AUTHORS >Wada Y</bp:AUTHORS>
      <bp:AUTHORS >Swendeman S</bp:AUTHORS>
      <bp:AUTHORS >Liu CH</bp:AUTHORS>
      <bp:AUTHORS >Blaho VA</bp:AUTHORS>
      <bp:AUTHORS >Nagumo R</bp:AUTHORS>
      <bp:AUTHORS >Satoh K</bp:AUTHORS>
      <bp:AUTHORS >Izumi T</bp:AUTHORS>
      <bp:AUTHORS >Hla T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c65">
      <bp:ID >30249788</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >N-terminal mutation of apoA-I and interaction with ABCA1 reveal mechanisms of nascent HDL biogenesis.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >2019</bp:YEAR>
      <bp:AUTHORS >Liu M</bp:AUTHORS>
      <bp:AUTHORS >Mei X</bp:AUTHORS>
      <bp:AUTHORS >Herscovitz H</bp:AUTHORS>
      <bp:AUTHORS >Atkinson D</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dd8">
      <bp:ID >14592533</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders.</bp:TITLE>
      <bp:SOURCE >Int J Biochem Cell Biol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Rhainds D</bp:AUTHORS>
      <bp:AUTHORS >Brissette L</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ce8">
      <bp:ID >26561703</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Hypertriglyceridemia: Pathophysiology, Role of Genetics, Consequences, and Treatment</bp:TITLE>
      <bp:SOURCE />
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Chait A</bp:AUTHORS>
      <bp:AUTHORS >Subramanian S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cbc">
      <bp:ID >31676439</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Interleukin 10 promotes macrophage uptake of HDL and LDL by stimulating fluid-phase endocytosis.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta Mol Cell Biol Lipids</bp:SOURCE>
      <bp:YEAR >2020</bp:YEAR>
      <bp:AUTHORS >Lucero D</bp:AUTHORS>
      <bp:AUTHORS >Islam P</bp:AUTHORS>
      <bp:AUTHORS >Freeman LA</bp:AUTHORS>
      <bp:AUTHORS >Jin X</bp:AUTHORS>
      <bp:AUTHORS >Pryor M</bp:AUTHORS>
      <bp:AUTHORS >Tang J</bp:AUTHORS>
      <bp:AUTHORS >Kruth HS</bp:AUTHORS>
      <bp:AUTHORS >Remaley AT</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >disease pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000013</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fdd">
      <bp:ID >29100061</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.</bp:TITLE>
      <bp:SOURCE >Atherosclerosis</bp:SOURCE>
      <bp:YEAR >2017</bp:YEAR>
      <bp:AUTHORS >Wolska A</bp:AUTHORS>
      <bp:AUTHORS >Dunbar RL</bp:AUTHORS>
      <bp:AUTHORS >Freeman LA</bp:AUTHORS>
      <bp:AUTHORS >Ueda M</bp:AUTHORS>
      <bp:AUTHORS >Amar MJ</bp:AUTHORS>
      <bp:AUTHORS >Sviridov DO</bp:AUTHORS>
      <bp:AUTHORS >Remaley AT</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bab">
      <bp:ID >28766509</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol.</bp:TITLE>
      <bp:SOURCE >Anatol J Cardiol</bp:SOURCE>
      <bp:YEAR >2017</bp:YEAR>
      <bp:AUTHORS >Tosheska Trajkovska K</bp:AUTHORS>
      <bp:AUTHORS >Topuzovska S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="edb">
      <bp:ID >23055695</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib.</bp:TITLE>
      <bp:SOURCE >Drug Des Devel Ther</bp:SOURCE>
      <bp:YEAR >2012</bp:YEAR>
      <bp:AUTHORS >Goldberg AS</bp:AUTHORS>
      <bp:AUTHORS >Hegele RA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ea2">
      <bp:ID >32557261</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Lomitapide-a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia.</bp:TITLE>
      <bp:SOURCE >Curr Atheroscler Rep</bp:SOURCE>
      <bp:YEAR >2020</bp:YEAR>
      <bp:AUTHORS >Stefanutti C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d2a">
      <bp:ID >22461740</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis.</bp:TITLE>
      <bp:SOURCE >Yale J Biol Med</bp:SOURCE>
      <bp:YEAR >2012</bp:YEAR>
      <bp:AUTHORS >Go GW</bp:AUTHORS>
      <bp:AUTHORS >Mani A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e47">
      <bp:ID >30420806</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Sexually Dimorphic Regulation of EET Synthesis and Metabolism: Roles of Estrogen.</bp:TITLE>
      <bp:SOURCE >Front Pharmacol</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Huang A</bp:AUTHORS>
      <bp:AUTHORS >Sun D</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >hyperlipoproteinemia type IV</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:1172</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bbc">
      <bp:ID >32120838</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Association between the&lt;i&gt;APOA2&lt;/i&gt;rs3813627 Single Nucleotide Polymorphism and HDL and APOA1 Levels Through BMI.</bp:TITLE>
      <bp:SOURCE >Biomedicines</bp:SOURCE>
      <bp:YEAR >2020</bp:YEAR>
      <bp:AUTHORS >Boughanem H</bp:AUTHORS>
      <bp:AUTHORS >Bandera-Merch&#195;&#402;&#194;&#161;n B</bp:AUTHORS>
      <bp:AUTHORS >Hern&#195;&#402;&#194;&#161;ndez-Alonso P</bp:AUTHORS>
      <bp:AUTHORS >Moreno-Morales N</bp:AUTHORS>
      <bp:AUTHORS >Tinahones FJ</bp:AUTHORS>
      <bp:AUTHORS >Lozano J</bp:AUTHORS>
      <bp:AUTHORS >Morcillo S</bp:AUTHORS>
      <bp:AUTHORS >Macias-Gonzalez M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e51">
      <bp:ID >20301485</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Familial Lipoprotein Lipase Deficiency</bp:TITLE>
      <bp:SOURCE />
      <bp:YEAR >1993</bp:YEAR>
      <bp:AUTHORS >Burnett JR</bp:AUTHORS>
      <bp:AUTHORS >Hooper AJ</bp:AUTHORS>
      <bp:AUTHORS >Hegele RA</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>